The global body mist market size was valued at $7.8 billion in 2023, is projected to reach $14.0 billion by 2035, growing at a CAGR of 5.0% from 2024 to 2035. WILMINGTON, NEW CASTLE, DE, UNITED STATES, July 18, 2025 /⁨EINPresswire.com⁩/ -- …

… particularly in the food industry. Furthermore, Andrii is … the company. The company has already demonstrated tangible business … the food, packaging, pharmaceutical, and machine-building industries … Kyiv, and Odesa, Ukraine, specializing in packaging equipment …

… Development Fund; Business leaders; Distinguished … investments to increase Green Field Investments, Infrastructure Investments … restructuring the industry. We … market growth, presents appealing potential for investors seeking to establish onshore pharmaceutical …

… to 24% in an Indian company without any approval being required … sectors such as manufacturing and pharmaceuticals, while some sensitive sectors such … globally since Russia';s invasion of Ukraine, the rules hampering Chinese investment in …

… 30th. Brad Bechtel of investment bank Jefferies says Waller’s … .40 EDT Shares in pharmaceuticals firm GSK have dropped … putting more pressure on Russia’s military industry, Chinese banks that … rolling coverage of business, the financial markets and the world …

… investors, and industry leaders to make data-backed decisions and navigate market … momentum and significant investment potential across regions … innovation, and usability. Pharmaceuticals, Healthcare Services, Medical … personnel in the business world in …

… in the pharmaceutical market of the Russian Federation, effectively … Ukrainian pharmaceutical company handed over the full package of documentation to the Russian … from doing business in the Russian Federation after … to the Russian Federation and Belarus, which …

… fueled by booming infrastructure investments, growing urbanization, … Laval Baker Hughes Company ​​Bosch Rexroth CIRCOR … Beverage Chemical Power Mining Pharmaceutical Others Geography APAC … reports contain detailed industry analysis, market size, share, …

Updated data from a phase 1b clinical trial (NCT03666000) evaluating azercabtagene zapreleucel (azer-cel; PBCAR0191), an investigational allogeneic, off-the-shelf chimeric antigen receptor (CAR) T-cell therapy, in combination with lymphodepletion and …

… during forced conscription in Ukraine, Hungary has banned … sanctions. Read more here Ukrainian guest workers: Reality vs. … more Economy & business Hungary–Uzbekistan trade boost Hungary … growing trade—especially in pharmaceuticals and vehicles—and open …